Cargando…
Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
Pimecrolimus cream 1% has shown to be effective in patients with a variety of inflammatory cutaneous disorders. And it might be a useful modality in the treatment of seborrheic dermatitis. This prospective study was aimed at assessing the efficacy and tolerability of pimecrolimus cream 1% in the tre...
Autores principales: | Kim, Byung-Soo, Kim, Su-Han, Kim, Moon-Bum, Oh, Chang-Keun, Jang, Ho-Sun, Kwon, Kyung-Sool |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693855/ https://www.ncbi.nlm.nih.gov/pubmed/17982237 http://dx.doi.org/10.3346/jkms.2007.22.5.868 |
Ejemplares similares
-
The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials
por: Alsmeirat, Odeh, et al.
Publicado: (2022) -
A Pilot Study of 1% Pimecrolimus Cream for the Treatment of Childhood Segmental Vitiligo
por: Shim, Woo-Haing, et al.
Publicado: (2013) -
Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study
por: Youn, Hae Jeong, et al.
Publicado: (2016) -
Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?
por: Beriat, Güçlü Kaan, et al.
Publicado: (2012) -
Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
por: Huang, Chunyun, et al.
Publicado: (2014)